[HTML][HTML] Association of CD49d expression with clinicopathological features of chronic lymphocytic leukemia patients in the Iranian population

P Nematollahi, M Shakery, A Kefayat… - International Journal of …, 2020 - ncbi.nlm.nih.gov
Background: Identification of factors affecting prognosis in chronic lymphocytic leukemia
(CLL) is important for risk stratification of patients. Methods: In the present study, CD49d …

Association of CD49d expression with clinicopathological features of chronic lymphocytic leukemia patients in the Iranian population.

P Nematollahi, M Shakery, A Kefayat… - International Journal of …, 2020 - europepmc.org
Background Identification of factors affecting prognosis in chronic lymphocytic leukemia
(CLL) is important for risk stratification of patients. Methods In the present study, CD49d …

[PDF][PDF] Association of CD49d expression with clinicopathological features of chronic lymphocytic leukemia patients in the Iranian population

P Nematollahi, M Shakery, A Kefayat… - Int J Physiol …, 2020 - researchgate.net
Background: Identification of factors affecting prognosis in chronic lymphocytic leukemia
(CLL) is important for risk stratification of patients. Methods: In the present study, CD49d …

[PDF][PDF] Association of CD49d expression with clinicopathological features of chronic lymphocytic leukemia patients in the Iranian population

P Nematollahi, M Shakery, A Kefayat… - Int J Physiol Pathophysiol …, 2020 - e-century.us
Background: Identification of factors affecting prognosis in chronic lymphocytic leukemia
(CLL) is important for risk stratification of patients. Methods: In the present study, CD49d …

Association of CD49d expression with clinicopathological features of chronic lymphocytic leukemia patients in the Iranian population

P Nematollahi, M Shakery… - … journal of physiology …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Identification of factors affecting prognosis in chronic lymphocytic leukemia
(CLL) is important for risk stratification of patients. Methods In the present study, CD49d …